bf/NASDAQ:CADL_icon.jpeg

NASDAQ:CADL

Candel Therapeutics, Inc.

  • Stock

USD

Last Close

1.54

28/03 20:00

Market Cap

34.85M

Beta: -

Volume Today

25.27K

Avg: 28.77K

PE Ratio

−2.46

PFCF: −1.09

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Market
  • website

    www.candeltx.com
  • ipo date

    Jul 23, 2021
  • full time employees

    76
  • currency

    USD

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prosta...Show More

Earnings per Share (Estimate*)

-0.6-0.4-0.20.20.42020-03-312020-12-312021-11-122022-05-122023-03-302023-08-10

Revenue (Estimate*)

5K10K15K20K25K30K35K2020-03-312020-12-312021-11-122022-05-122023-03-302023-08-10

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.